Effects of electrophysiologic-guided therapy with Class IA antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome

Journal of Cardiovascular Electrophysiology

Volumn 10, Issue 10, 1999, Pages 1301-1312

  Belhassen, Bernard ^a,b   Viskin, Sami ^a   Fish, Roman ^a   Glick, Aharon ^a   Setbon, Israel ^a   Eldar, Michael ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Brugada syndrome; Class IA antiarrhythmic drugs; Electrophysiologic study; Idiopathic ventricular fibrillation; Quinidine

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; DISOPYRAMIDE; PROCAINAMIDE; QUINIDINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; DRUG MECHANISM; DRUG SAFETY; FEMALE; HEART ELECTROPHYSIOLOGY; HEART STIMULATION; HEART VENTRICLE FIBRILLATION; HUMAN; IDIOPATHIC DISEASE; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SINUS RHYTHM; SYNDROME;

EID: 0032869692     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.1999.tb00183.x     Document Type: Article

References (35)

1. Viskin S, Belhassen B: Idiopathic ventricular fibrillation. Am Heart J 1990; 120:661-671.
2. Belhassen B, Viskin S: Idiopathic ventricular tachycardia and fibrillation. J Cardiovasc Electrophysiol 1993; 4:356-368.
3. Viskin S, Belhassen B. Polymorphic ventricular tachyarrhythmias in the absence of heart disease: Classification, differential diagnosis, and implications for therapy. Prog Cardiovasc Dis 1998;41:1-19.
4. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992; 20:1391-1396.
5. Chen Q, Kirsch G, Zhang D, et al: Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998:392:293-296.
6. Belhassen B, Pelleg A, Miller HI, et al: Serial electro-physiological studies in a young patient with recurrent ventricular fibrillation. PACE 1981:4:92-99.
7. Belhassen B, Shapira I, Shoshani D, et al. Idiopathic ventricular fibrillation: Inducibility and beneficial effects of class I antiarrhythmic agents. Circulation 1987; 75:809-816.
8. Leenhardt A, Lucet V, Denjoy I, et al: Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation 1995;91:1512-1519.
9. Belhassen B, Shapira I, Sheps D, et al. Programmed ventricular stimulation using up to two extrastimuli and repetition of double extrastimulation for induction of ventricular tachycardia: A new highly sensitive and specific protocol. Am J Cardiol 1990;65:615-622.
10. Aizawa Y, Naitoh N, Washizuka T, et al. Electrophysiological findings in idiopathic recurrent ventricular fibrillation: Special reference to mode of induction, drug testing and long-term outcomes. PACE 1996:19:929-939.
11. Lemery R, Brugada P, Delia Bella P, et al: Ventricular fibrillation in six adults without overt heart disease. J Am Coll Cardiol 1989;13:911-916.
12. Brugada J, Brugada P: Right bundle branch block and ST segment elevation in leads VI through V3. A marker for sudden death in patients without demonstrable structural heart disease. Circulation 1998;97:457-460.
13. Tung R, Shen W, Hammill S, et al: Idiopathic ventricular fibrillation in out-of-hospital cardiac arrest survivors. PACE 1994;17:1405-1412.
14. Meissner M, Lehmann M, Steinman R, et al. Ventricular fibrillation in patients without significant structural heart disease: A multicenter experience with implantable cardioverter-defibrillator therapy. J Am Coll Cardiol 1993;21:1406-1412.
15. Wever EFD, Hauer RNW, Oomen A, et al: Unfavorable outcome in patients with primary electrical disease who survived an episode of ventricular fibrillation. Circulation 1993;88:1021-1029.
16. Wellens HJJ, Lemery R, Smeets JL, et al: Sudden arrhythmic death without overt heart disease. Circulation 1992;85(Suppl I):1-92-1-97.
17. Mewis C, Kuhlkamp V, Spyridopoulos I, et al: Late outcome of survivors of idiopathic ventricular fibrillation. Am J Cardiol 1998;81:999-1003.
18. Priori S, Borggrefe M, Camm AJ, et al: Role of programmed electrical stimulation in the identification of effective pharmacologic therapy in patients with idiopathic ventricular fibrillation. (Abstract) Circulation 1995; 92:1-98.
19. Brugada P, Green M, Abdollah H, et al. Significance of ventricular arrhythmias initiated by programmed ventricular stimulation: The importance of the type of ventricular arrhythmia induced and the number of premature stimuli required. Circulation 1984;69:87-92.
20. Buxton AE, Waxman HL, Marchlinski FE, et al: Role of triple extrastimulation during electrophysiologic study of patients with documented sustained ventricular arrhythmias. Circulation 1984;69:532-540.
21. Viskin S, Lesh M, Eldar M, et al. Mode of onset of malignant ventricular arrhythmias in idiopathic ventricular fibrillation. J Cardiovasc Electrophysiol 1997;8: 1115-1120.
22. Otto C, Tauxe R, Cobb L, et al: Ventricular fibrillation causes sudden death in Southeast Asian immigrants. Ann Intern Med 1984; 100:45-47.
23. Garg A, Finneran W, Feld GK: Familial sudden cardiac death associated with a terminal QRS abnormality on surface 12-lead electrocardiogram in the index case. J Cardiovasc Electrophysiol 1998;9:642-647.
24. Wyse D, Mitchell L, Duff H. Procainamide, disopyramide and quinidine: Discordant antiarrhythmic effects during crossover comparison in patients with inducible ventricular tachycardia. J Am Coll Cardiol 1987;9:882-889.
25. Nademanee K, Veerakul G, Nimmannit S, et al: Arrhythmogenic marker for the sudden unexpected death syndrome in Thai men. Circulation 1997;96:2595-2600.
26. Kasanuki H, Ohnishi S, Ohtuka M, et al: Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease. Circulation 1997;95:2277-2285.
27. Antzelevitch C: The Brugada syndrome. J Cardiovasc Electrophysiol 1998;9:513-516.
28. Gussak I, Antzelevitch C, Bjerregaard P, et al. The Brugada syndrome: Clinical, electrophysiological and genetic aspects. J Am Coll Cardiol 1999;33:5-15.
29. Saumarez R, Heald S, Gill J, et al. Primary ventricular fibrillation is associated with increased paced right ventricular electrogram fractionation. Circulation 1995;92: 2565-2571.
30. Peeters H, Sippensgroenewegen A, Wever E, et al: Electrocardiographic identification of abnormal ventricular depolarization and repolarization in patients with idiopathic ventricular fibrillation. J Am Coll Cardiol 1998;31:1406-1413.
31. Priori S, Paganini V. Idiopathic ventricular fibrillation: A clinical prognostic and therapeutic dilemma. Data from the international registry of IVF (UCARE). (Abstract). Eur JCPE 1996;6:5.
32. Moe T: Morgagni-Adams-Stokes attacks caused by transient recurrent ventricular fibrillation in a patient without apparent heart disease. Am Heart J 1949;37:811-818.
33. Konty F, Dale J. Self-terminating idiopathic ventricular fibrillation presenting as syncope: A 40-year follow-up report. J Intern Med 1990;227:211-213.
34. Guidelines for the use of implantable cardioverter defibrillators. A Task Force of the Working Groups on Cardiac Arrhythmias and Cardiac Pacing of the European Society of Cardiology. Eur Heart J 1992; 13:1304-1310.
35. Brugada J, Brugada P: What to do in patients with no structural heart disease and sudden arrhythmic death? Am J Cardiol 1996;78(Suppl 5A):69-75.